Our comprehensive guide hospitals information helps you quickly locate a hospital anywhere in the world. Our database contains in excess of 16,000 hospitals, making it one of the best places to find information on the hospital you are searching for. To assist you with locating a hospital, you can refine your search by selecting the country in which the hospital is located and choose to search by either hospital name, city/town or state/county.

 Home>> Macugen (pegaptanib)

Macugen (pegaptanib)

General Information

Macugen (pegaptanib) is a selective vascular endothelial growth factor (VEGF) antagonist.

Macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration. According to the present product label, Macugen (0.3 mg) should be administered once every six weeks by intravitreous injection into the eye to be treated.

There are 15 million people in the United States living with some form of AMD, with more than 1.6 million experiencing the active blood vessel growth and blood vessel leakage associated with neovascular AMD.


Additional Information

For additional information regarding Macugen or macular degeneration, please visit The Macugen Web Site


Clinical Results

FDA approval of Macugen was based on results from two controlled, double-masked, randomized trials (study EOP1003 & EOP1004) enrolling a total of 1,200 patients with neovascular AMD. Subjects received 0.3 mg, 1 mg or 3 mg if Macugen by injection or a control (sham) treatment every 64 days for 48 weeks. The median age of the patients was 77 years. All subjects enrolled had classic, occult, or mixed lesions of up to 12 disc areas and baseline visual acuity in the study eye between 20/40 and 20/320.

Results showed that treatment with Macugen demonstrated statistically significant less vision loss compared to sham treatment. Results showed that among patients receiving 0.3 mg of Macugen, 70% lost less than three lines of vision on the eye chart, compared with 55% of patients receiving control treatment (P<.0001). The results demonstrated a 27% relative treatment effect for Macugen treated patients compared to controls with respect to three line loss. Macugen also helped limit progression to legal blindness, by 50 % compared to controls, in the study eye.More sham treated patients (75/296) received PDT than Macugen 0.3 mg treated patients (58/294).

On average, Macugen 0.3 mg treated patients and sham treated patients continued to experience vision loss. The rate of vision decline in the Macugen treated group was slower than the rate in the patients who received sham treatment. In both studies, the primary endpoint was the proportion of patients losing less than 15 letters of visual acuity, from baseline up to 54 week assessment.


Mechanism of Action

Pegaptanib is a selective vascular endothelial growth factor (VEGF) antagonist. VEGF is a secreted protein that selectively binds and activates its receptors located primarily on the surface of vascular endothelial cells. VEGF induces angiogenesis, and increases vascular permeability and inflammation, all of which are thought to contribute to the progression of the neovascular (wet) form of age-related macular degeneration (AMD), a leading cause of blindness.


Literature References

Side effects

Adverse events associated with the use of Macugen may include (but are not limited to) the following:


  • Ocular Discomfort
  • Eye Pain
  • Endophthalmitis
  • Reduced Visual Acuity
  • Visual Disturbance
  • Corneal Edema
  • Blurred Vision
  • Dizziness

Treatment

Macular Degeneration

Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Glyburide Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onglyza (saxagliptin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Teczem (enalapril maleate/diltiazem malate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Renagel (sevelamer hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Fycompa (perampanel) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Orbactiv (oritavancin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print UVADEX Sterile Solution Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Dynabac Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ragwitek (Short Ragweed Pollen Allergen Extract) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Raplon Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prolia (denosumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Humira (adalimumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Anthim (obiltoxaximab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Requip (ropinirole hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Amevive (alefacept) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print laViv (azficel-T) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print MERIDIA Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Olysio (simeprevir) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pepcid Complete Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Protonix (pantoprazole sodium) Delayed-Release Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Coartem (artemether/lumefantrine) Tekamlo (aliskiren + amlodipine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pindolol Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Paxil (paroxetine hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Infasurf Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Imitrex (sumatriptan) nasal spray Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Altocor (lovastatin) Extended-Release Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Otiprio (ciprofloxacin otic suspension) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cayston (aztreonam for inhalation solution) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print INFERGEN (interferon alfacon-1) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Vogelxo (testosterone) gel Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Remeron SolTab (mirtazapine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Adempas (riociguat) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Antizol Injection Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Votrient (pazopanib) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Oral Cytovene Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Estratab (.3 mg ) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Nuplazid (pimavanserin)